Status:
COMPLETED
The Effect of Intrathecal Magnesium Sulfate on Shivering
Lead Sponsor:
Yuzuncu Yil University
Conditions:
Magnesium Sulfate Causing Adverse Effects in Therapeutic Use
Postoperative Shivering
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Shivering after spinal anesthesia is a common complication. Mangesium sulfate, which can be used intrathecally, is effective in preventing tremor. But what is the ideal dose?
Detailed Description
Perioperative shivering during cesarean section (CS) under neuraxial anesthesia (NA) is clinically common, but its treatment is often neglected. When the literature is scanned, perioperative tremors ...
Eligibility Criteria
Inclusion
- Who were scheduled for elective C/S under SA,
- 18-40 years of age
- ASA physical status I-II.
Exclusion
- Any contraindications to SA,
- preoperative body temperature \>38 C,
- allergy to any drug used in the study,
- pre-eclampsia, and eclampsia,
- neuropathy,
- respiratory distress,
- coagulopathy, and
- any possible drugs that can change body temperature,
- ASA physical status \> II.
Key Trial Info
Start Date :
May 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05427149
Start Date
May 10 2022
End Date
August 30 2022
Last Update
September 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Van yuzuncu Yıl University, Dursun Odabas Medical Center
Van, Turkey (Türkiye), 65080